Caoilfhionn M Connolly Selected Research

Musculoskeletal Diseases (Musculoskeletal Disease)

4/2022	Antibody durability 6 months after two doses of SARS-CoV-2 mRNA vaccines in patients with rheumatic and musculoskeletal disease.
1/2022	Disease Flare and Reactogenicity in Patients With Rheumatic and Musculoskeletal Diseases Following Two-Dose SARS-CoV-2 Messenger RNA Vaccination.
10/2021	Antibody response to the Janssen/Johnson & Johnson SARS-CoV-2 vaccine in patients with rheumatic and musculoskeletal diseases.
1/2021	Absence of Humoral Response After Two-Dose SARS-CoV-2 Messenger RNA Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: A Case Series.
1/2021	Antibody response to a single dose of SARS-CoV-2 mRNA vaccine in patients with rheumatic and musculoskeletal diseases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Caoilfhionn M Connolly Research Topics

Disease

5	Musculoskeletal Diseases (Musculoskeletal Disease) 04/2022 - 01/2021
2	COVID-19 01/2022 - 09/2021
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 10/2022
1	Proteinuria 10/2022
1	Systemic Scleroderma (Systemic Sclerosis) 07/2022
1	Myositis (Idiopathic Inflammatory Myopathies) 01/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022
1	Rheumatic Diseases (Rheumatism) 11/2021

Drug/Important Bio-Agent (IBA)

5	Messenger RNA (mRNA)IBA 01/2022 - 01/2021
2	mRNA VaccinesIBA 04/2022 - 01/2021
1	Lipoprotein(a)IBA 10/2022
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 07/2022
1	insulin receptor-related receptor (IRR)IBA 01/2022
1	COVID-19 VaccinesIBA 10/2021
1	Methotrexate (Mexate)FDA LinkGeneric 09/2021

Therapy/Procedure

1	Immunomodulation 01/2022
1	Therapeutics 01/2022